RAPP EDWARD J 4

What Happened

• Edward J. Rapp, a director of AbbVie Inc. (ABBV), received 134 shares (reported as a derivative award) on 2026-06-30. The award is recorded at $251.64 per share, for a total value of approximately $33,720. This was an award/credit of stock-equivalent units tied to director compensation, not an open-market purchase or sale.

Key Details

• Transaction date and terms: 2026-06-30 — 134 shares @ $251.64 each (total ≈ $33,720); reported on Form 4 filed 2026-07-02 (Accession 0001171780-26-000012).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 — Director fees were credited to a stock-equivalent unit account in a grantor trust and are distributed over a period tied to the director’s years of board service (distribution typically begins at age 65 or upon retirement). F2 — Balance includes units from a dividend reinvestment feature.
• Filing timeliness: Form 4 filed 2026-07-02; no late-filing flag noted on the reported document.

Context

• This was a routine director compensation award converted into stock-equivalent units (a derivative), which are tracked in a grantor trust and paid out later per the trust terms. Such awards reflect deferred compensation and do not necessarily indicate immediate buying or selling intent.